Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praphan Phanuphak

Showing results (151-160 of 219) with videos related to

Pageof 22
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, ThailandWin M Han, Donn J Colby, Apichaya Khlaiphuengsin, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2008
Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adultsJasper van der Lugt, Reshma Saskia Autar, Sasiwimol Ubolyam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2014
Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East AsiaPraphan Phanuphak, Sunee Sirivichayakul, Awachana Jiamsakul, et al.
Clinical Pharmacokinetics|December 31, 2015
Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 StudyLaura Dickinson, Janaki Amin, Laura Else, et al.
Plos One|November 23, 2013
Use of human papillomavirus DNA, E6/E7 mRNA, and p16 immunocytochemistry to detect and predict anal high-grade squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with menNittaya Phanuphak, Nipat Teeratakulpisarn, Somboon Keelawat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infectionChaiwat Ungsedhapand, Preeyaporn Srasuebkul, Peter Cardiello, et al.
Antiviral Therapy|December 11, 2012
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapineNittaya Phanuphak, Jintanat Ananworanich, Nipat Teeratakulpisarn, et al.
The Lancet. Infectious Diseases|December 4, 2014
The future role of CD4 cell count for monitoring antiretroviral therapyNathan Ford, Graeme Meintjes, Anton Pozniak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 studyPeter G Cardiello, Rolf P van Heeswijk, Elly A Hassink, et al.
Journal of the International AIDS Society|July 12, 2019
Switch to dolutegravir is well tolerated in Thais with HIV infectionOrlanda Q Goh, Donn J Colby, Suteeraporn Pinyakorn, et al.
Pageof 22

Showing results (151-160 of 219) with videos related to

Sort By:
Pageof 22
Liver International : Official Journal of the International Association for the Study of the Liver|June 24, 2020
Large transmission cluster of acute hepatitis C identified among HIV-positive men who have sex with men in Bangkok, ThailandWin M Han, Donn J Colby, Apichaya Khlaiphuengsin, et al.
The Journal of Antimicrobial Chemotherapy|February 21, 2008
Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adultsJasper van der Lugt, Reshma Saskia Autar, Sasiwimol Ubolyam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2014
Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East AsiaPraphan Phanuphak, Sunee Sirivichayakul, Awachana Jiamsakul, et al.
Clinical Pharmacokinetics|December 31, 2015
Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 StudyLaura Dickinson, Janaki Amin, Laura Else, et al.
Plos One|November 23, 2013
Use of human papillomavirus DNA, E6/E7 mRNA, and p16 immunocytochemistry to detect and predict anal high-grade squamous intraepithelial lesions in HIV-positive and HIV-negative men who have sex with menNittaya Phanuphak, Nipat Teeratakulpisarn, Somboon Keelawat, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2004
Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infectionChaiwat Ungsedhapand, Preeyaporn Srasuebkul, Peter Cardiello, et al.
Antiviral Therapy|December 11, 2012
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapineNittaya Phanuphak, Jintanat Ananworanich, Nipat Teeratakulpisarn, et al.
The Lancet. Infectious Diseases|December 4, 2014
The future role of CD4 cell count for monitoring antiretroviral therapyNathan Ford, Graeme Meintjes, Anton Pozniak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2002
Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 studyPeter G Cardiello, Rolf P van Heeswijk, Elly A Hassink, et al.
Journal of the International AIDS Society|July 12, 2019
Switch to dolutegravir is well tolerated in Thais with HIV infectionOrlanda Q Goh, Donn J Colby, Suteeraporn Pinyakorn, et al.
Pageof 22